Welcome to BioMarin’s Investor Relations & Media Page

We’ve brought together a variety of information in one location to better assist you in your efforts to research and develop news articles and learn about our company.

BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.

Recent News
Mar 3, 2021
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the company has completed full enrollment in a global Phase 2 randomized, placebo-controlled study of vosoritide, an...

Feb 25, 2021
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited) Three Months Ended December 31, Twelve Months Ended December 31, 2020 2019 % Change 2020 2019 % Change Total...

Feb 24, 2021
BioMarin to Participate in Four Upcoming Virtual Investor Conferences

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences. An audio webcast of the presentations will be available live. You...

Events & Presentations
Barclays Global Healthcare Conference
Tuesday, March 9, 2021
2:25pm - 2:50pm EST
Add to Calendar
Set Email Reminder
10th Annual J.P. Morgan Napa Valley Forum
Monday, March 29, 2021
1:00pm - 1:45pm EDT
Add to Calendar
Set Email Reminder

Stock Quote
NASDAQBMRN